With this change, we found that there were significant associations between the ADRB2 A46G polymorphism and essential hypertension risk under four genetic models: allele genetic model (OR: 1.14, 95% CI: 1.06–1.23, P = .001, Pheterogeneity = .09), homozygote genetic model (OR: 1.29, 95% CI: 1.11–1.51, P = .001, Pheterogeneity = .25), dominant genetic model (OR: 1.17, 95% CI: 1.05–1.32, P = .005, Pheterogeneity = .04), and recessive genetic model (OR: 1.21, 95% CI: 1.05–1.38, P = .007, Pheterogeneity = .72) (Fig. 3A-3E and Table 4). Here, ADRB2 is linked to essential hypertension.